CRI Logo
  • About
    • Impact
    • History
    • Team
    • Careers
    • Blog
    • Media Room
  • What is Immunotherapy?
    • Immunotherapy Basics
    • Treatment Types
    • Cancer Types
    • Side Effects
  • Patient Support
    • Patient Resources
    • Clinical Trials
    • Immunotherapy Stories
    • Connect with ImmunoAdvocates
  • Grants & Research Programs
    • Apply for Grants
    • Research Programs
    • Clinical Programs
    • Data Programs
    • CRI Funded Scientists
  • Get Involved
    • Ways to give
    • Fundraise
    • Events
    • Partnership
    • Contact
Donate

Immune to Cancer: The CRI Blog

  • New Philanthropy Partnership with GuideVine

    New year, new partnerships! On January 1, 2016, GuideVine Technologies, Inc., announced the Cancer Research Institute as…

    January 27, 2016| Katherine McCluskey
  • Biden’s Cancer “Moonshot”: PBS Interview with CRI Scientist

    Vice President Joe Biden declared that we are going to take a “moonshot” at cancer, to cure…

    January 22, 2016| Arthur N. Brodsky, PhD
  • Business Insider Credits CRI with Pioneering Field of Cancer Immunotherapy

    Jimmy Carter’s successful treatment with immunotherapy is thanks to CRI’s pioneering work, says Business Insider.

    January 6, 2016| Brian Brewer
  • CRI’s 9 Favorite Blogs from 2015

    Missed any of our blog posts this year? We reflect back on our favorites.

    December 30, 2015| Michelle Liew
  • William Coley and Cancer Immunotherapy Spotlighted on NPR

    The Cancer Research Institute received a very special holiday treat this morning, with a prominent mention at…

    December 28, 2015| Jill O'Donnell-Tormey, PhD
  • Immunotherapy Approvals in 2015

    In 2015, the FDA approved more immunotherapies than in any prior year.

    December 24, 2015| Alexandra Mulvey
  • Top 5 Cancer Immunotherapy Stories of 2015

    Here’s what you, our online community, thought were the biggest stories of 2015.

    December 22, 2015| Emily Helck
  • CRI Scientific Advisory Council Member Elected NAI Fellow

    Pramod K. Srivastava, MD, PhD, a CRI Scientific Advisory Council member, was elected a Fellow in the National…

    December 15, 2015| Arthur N. Brodsky, PhD
  • CRI Partners with the Lymphoma Research Foundation to Improve Immunotherapy Evaluation Guidelines for Lymphoma

    CRI, LRF work towards better immunotherapy guidelines for lymphoma.

    December 11, 2015| Arthur N. Brodsky, PhD
Previous Page
1 … 74 75 76 77 78 … 92
Next Page
Father and son

Join CRI in Shaping the Future of Immunotherapy

Support the pioneering work of CRI in advancing immunotherapy.

See ways to give

Cancer Research Institute
29 Broadway, Floor 4

New York, NY  10006-3111

Facebook Icon
X icon
YouTube icon
LinkedIn icon
Instagram icon
Threads icon
  • About
    • Impact
    • History
    • Team
    • Careers
    • Blog
    • Media Room
  • What is Immunotherapy?
    • Immunotherapy Basics
    • Treatment Type
    • Cancer Type
    • Side Effects
  • Patient Support
    • Patient Resources
    • Clinical Trials
    • Immunotherapy Stories
    • Connect with ImmunoAdvocates
  • Grants & Research Programs
    • Apply for Grants
    • Research Programs
    • Clinical Programs
    • Data Programs
    • CRI Funded Scientists
  • Get Involved
    • Donate
    • Ways to give
    • Fundraise
    • Events
    • Partnership
    • Contact

Uniting for a World Immune to Cancer

  • Accessibility Statement
  • Privacy Policy
  • Terms & Conditions
  • Site Map

*Immunotherapy results may vary from patient to patient.

©2025, Cancer Research Institute